Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price rose 21.2% during mid-day trading on Thursday . The company traded as high as C$0.21 and last traded at C$0.20. Approximately 292,294 shares changed hands during mid-day trading, a decline of 46% from the average daily volume of 538,273 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Price Performance
The business’s fifty day moving average is C$0.11 and its 200-day moving average is C$0.08. The firm has a market cap of C$25.10 million, a PE ratio of -18.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- About the Markup Calculator
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- What Are Dividend Contenders? Investing in Dividend Contenders
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Canadian Penny Stocks: Can They Make You Rich?
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
